Corticosteroid treatment for severe erythema multiforme
Treatments studied
Part of Skin clinical trials.
This trial tests whether a short course of corticosteroid pills can help control severe erythema multiforme, a painful skin condition with target-like red patches, faster than usual care. It focuses on people whose rash is severe enough to affect eating, and it's especially relevant for those experiencing their first episode or a sudden flare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 15 years or older and weigh between 66 and 330 pounds
- You must have a confirmed diagnosis of severe erythema multiforme, where the rash affects at least two moist areas (like mouth, eyes, or genitals) or severely affects your mouth with trouble eating solid food
- Your current flare must have started within the last 5 days
- You must not have other conditions like Stevens-Johnson syndrome, toxic epidermal necrolysis, or pemphigus
- You must not be taking corticosteroids for other reasons, and you must not have taken them long-term for previous EM flares
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This study tests an oral medication (EC-18) for moderate to severe atopic dermatitis (eczema) to see if it can improve symptoms like itching and skin rash. It may be an option for people whose eczema is not controlled by topical treatments.
This Phase 3 trial tests how an investigational medicine (PF-06823859) works in adults with active dermatomyositis or polymyositis. It aims to improve disease control by targeting the immune system, but you must meet several safety and diagnosis requirements.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This study tests a moisturizing cream (FilmoCream) used together with a steroid cream to treat eczema (atopic dermatitis). It aims to see if this combination works better than using the steroid cream alone on mild to moderate eczema.
This trial tests whether a course of steroid medicine can improve outcomes in people with recently started myocarditis (heart muscle inflammation) and mildly reduced heart pumping. It compares steroids versus placebo (inactive treatment) to see if steroids help the heart recover and prevent worsening.
Hear when a new Erythema Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.